Amazon to Expand Drone Delivery to 500 U.S. Locations 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
Apple Cuts Over 200 Siri, Vision Pro Jobs in AI Shift 
Trump Buys SpaceX Shares After Record IPO 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Exxon, LyondellBasell Eye Shell’s $8 Billion U.S. Chemicals Assets 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
Tesla Raises Cybertruck Prices by $5,000 in US 
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Nvidia Options Price in $280 Billion Earnings Swing 
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
KPMG Australia Cuts 5% of Workforce Amid Scandal 
Add as a preferred source on Google
GAITHERSBURG, Md., May 01, 2018 -- OpGen, Inc. (NASDAQ:OPGN) announced today that the Company will report financial results for the three months ended March 31, 2018 after close of the U.S. financial markets on Tuesday, May 8, 2018. OpGen’s management team will host a live conference call and webcast at 4:30 p.m. Eastern time to discuss the Company’s financial results and business progress.
Dial-in Information
U.S. Dial-In Number: (888) 883-4599
International Dial-In Number: (484) 653-6821
Conference ID: 1082196
Replay Dial-in Information
U.S. Dial-In Number: (855) 859-2056
International Dial-In Number: (404) 537-3406
Conference ID: 1082196
Following the conclusion of the conference call, a replay will be available through May 14, 2018. The live, listen-only webcast of the conference call may also be accessed by visiting the investors section of the Company’s website at http://ir.opgen.com. A replay of the webcast will be available after the conclusion of the call and will be archived on the Company’s website for 90 days.
About OpGen
OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. For more information, please visit www.opgen.com.
OpGen Contact:
Michael Farmer
Vice President, Marketing
(240) 813-1284
[email protected]
[email protected]
Investor Contacts:
LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
[email protected]
or
Bruce Voss
(310) 691-7100
[email protected]
